Clinical trial
An Open-Label Study to Assess the Safety and Efficacy of GC012F in Patients With Multiple Sclerosis
NCT07364487 is registered in ClinicalTrials.gov with Huashan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open-Label Study to Assess the Safety and Efficacy of GC012F in Patients With Multiple Sclerosis
- Lead sponsor
- Huashan Hospital
- Phase
- Phase 1
- Overall status
- Withdrawn
- Start date
- January 26, 2026
- Completion date
- March 25, 2026
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.